Abstract: Various surgical tissue anchor retention mechanisms, systems and methods are provided. The mechanisms, systems and methods can include a delivery tool or needle having a flex joint, a snap-fit, a cam and follower, a rotating tip, an expandable lock, a coil, an inverted collet, a tab, a buckling tube, an inflation element or like anchor retention or securement features.

Abstract: Various embodiments of a pelvic treatment system and method are provided. The present invention can include one or more drug eluting darts or barbs that are lodged into the wall and will elute the drug over a desired time period (weeks, months for example) to treat OAB, BPH, tissue weaknesses, or other disorders or diseases.

Abstract: Surgical articles, implants and components suitable for female pelvic health procedures are described.

Abstract: A fluid management system includes a pump configured to pump fluid through the system at a fluid flow rate. The system includes a processor including a user interface, the user interface allowing a user to input a set of system operating parameters, the processor being configured to control the pump to maintain a target fluid flow rate based on the set of system operating parameters. The system further includes a scope device coupled to the pump to deliver fluid to a target surgical site, the scope device including an elongated shaft extending from a distal end thereof, the elongated shaft including at least one sensor, the sensor transmitting sensor data relating to target surgical site to the processor. The processor automatically signals to the pump to adjust the fluid flow rate based on the sensor data.

Abstract: An optical device including an optical fiber having a longitudinal axis and an optical fiber core with a distal end having a distal terminating end configured to discharge a first laser energy in a first direction and a second laser energy in a second direction. The optical device also includes a fiber cap having an interior cavity and an opening to the interior cavity, where the distal end of the optical fiber core is received within the interior cavity through the opening. A cladding is included on the distal end of the optical fiber core between the optical fiber core and the fiber cap.

Abstract: An optical device including an optical fiber having a longitudinal axis and an optical fiber core with a distal end having a distal terminating end configured to discharge a first laser energy in a first direction and a second laser energy in a second direction. The optical device also includes a fiber cap having an interior cavity and an opening to the interior cavity, where the distal end of the optical fiber core is received within the interior cavity through the opening. A cladding is included on the distal end of the optical fiber core between the optical fiber core and the fiber cap.

Abstract: A drug delivery system that can be deployed from a catheter and retained within the bladder for delivery of treatment drug solutions over a period of time. The delivery system includes an inflatable or expandable delivery element that can be collapsed within the catheter tip for navigation into the bladder before being inflated or expanded within the bladder. The inflated or expanded delivery element can engage the bladder walls or sized to be too large to be passed from the bladder such that the delivery element is retained within the bladder after inflation or expansion to administer a treatment drug solution over an extended period of time.

Abstract: Aspects of access devices and methods are disclosed. One aspect of this disclosure is a device. The device may comprise: a needle guide body extending along a central axis between a distal end and a proximal end, a needle guide lumen extending through the distal and proximal ends of the needle guide body along the central axis, and a base monolithically attached to the needle guide body to define a non-variable patient-specific insertion path. Additional devices and methods are disclosed.

Abstract: Disclosed is a surgical system for positioning an implant in a patient. The surgical system includes an insertion needle and a connector. The insertion needle has a distal end with a channel formed therein. The channel has a first end and a second end. The first end extends to the distal end. The second is laterally offset from the first end and does not extend to the distal end. The connector has a first end and a second end. The first end is attached to the implant that is to be positioned in the patient. The second end has a recess formed therein. The recess generally conforms to the distal end of the insertion needle. The connector has an inwardly directed extension that extends into the recess. The inwardly directed extension engages the insertion needle through the channel.

Abstract: An implantable electrode assembly configured to deliver electrical stimulation signals to tissue of a patient includes an implantable mesh comprising a plurality of electrically conductive wires. A plurality of electrodes are fastened to the electrically conductive wires. The electrodes include a stimulation surface and an electrically conductive path between the stimulation surface and the wire, to which the electrode is attached. In one embodiment, the plurality of electrodes each comprise first and second members that are fastened together around one of the electrically conductive wires.

Abstract: The present invention includes a method of implanting a urethral prosthesis. The method includes making an incision, positioning arms of the prosthesis in the pelvic region of the patient, and positioning a stem of the prosthesis in the scrotum of the patient.

Abstract: A surgical instrument for treating incontinence includes a handle portion elongate along a handle axis and a needle portion connected to the handle portion. The needle portion has a spacer portion along the handle axis, and has a distal end. The needle portion includes a substantially helical portion that is a variable spiral portion, extending from the straight spacer portion. The variable spiral portion is sized and shaped to extend from an incision substantially adjacent the patient's obturator foramen through the obturator foramen along a path in a region between the superior pubic ramus and the inferior pubic ramus. The needle portion has a structure near the distal end that associates the instrument with an implantable material configured to treat incontinence.

Abstract: A surgical instrument for treating incontinence includes a handle portion elongate along a handle axis and a needle portion connected to the handle portion. The needle portion has a spacer portion along the handle axis, and has a distal end. The needle portion includes a substantially helical portion that is a variable spiral portion, extending from the straight spacer portion. The variable spiral portion is sized and shaped to extend from an incision substantially adjacent the patient's obturator foramen through the obturator foramen along a path in a region between the superior pubic ramus and the inferior pubic ramus. The needle portion has a structure near the distal end that associates the instrument with an implantable material configured to treat incontinence.

Abstract: In a method, an implantable mechanical support is provided. The mechanical support includes a section of mesh having a longitudinal axis and a radiopaque mark covering a subsection of the section of mesh. The mechanical support is implanted adjacent a target side of a patient. In some aspects of the method, a procedure is performed subsequent to the implantation of the mechanical support in the patient. In accordance with one aspect of the method, an incision is made in the patient, a distal end of an electrode lead is fed through the incision toward the implanted mechanical support. The radiopaque mark is located on the mesh using a radiological image. The distal end of the electrode lead is attached to the section of mesh proximate to the mark.

Abstract: Biodegradable implants including an ECM material and methods for treating a pelvic floor condition are described. ECM particles can be present within or on the surface of a pelvic implant, such as a biodegradable mesh, a pouch, or a urethral stent. After implantation the implant can provide tissue support, degrade over a period of time, and deposit the ECM material in the implantation area for regeneration of tissue and long term benefit.

Abstract: A catheter based drug delivery system for minimally invasive delivery of treatment drugs into a bladder wall. The catheter system can include a delivery tip for deforming the bladder wall before forming jets of drug solution that penetrate the bladder wall for needleless delivery of the treatment drugs directly to the diseased tissue. The delivery tip can also have graduated markings for providing visual indicators of the relative depth of the delivery tip in the bladder wall and the alignment of the formed jets with the particular layers of the bladder wall.

Abstract: Various embodiments of a pelvic treatment system and method are provided. The present invention can include one or more drug eluting darts or barbs that are lodged into the wall and will elute the drug over a desired time period (weeks, months for example) to treat OAB, BPH, tissue weaknesses, or other disorders or diseases.

Abstract: The present invention provides a urethral prosthesis including a first and a second arm that join to form a junction, and a stem that is also joined to the junction. The junction is adapted to exert sufficient pressure on a portion of a patient's urethra to prevent unintentional voiding of the patient's bladder. However, upon exerting a tension force on the stem, the pressure exerted by the junction is reduced such that the patient's bladder may be intentionally voided.

Abstract: Various embodiments of a pelvic treatment system and method are provided. The present invention can include one or more drug eluting darts or barbs that are lodged into the wall and will elute the drug over a desired time period (weeks, months for example) to treat OAB, BPH, tissue weaknesses, or other disorders or diseases.

Abstract: A drug delivery system that can be deployed from a catheter and retained within the bladder for delivery of treatment drug solutions over a period of time. The delivery system includes an inflatable or expandable delivery element that can be collapsed within the catheter tip for navigation into the bladder before being inflated or expanded within the bladder. The inflated or expanded delivery element can engage the bladder walls or sized to be too large to be passed from the bladder such that the delivery element is retained within the bladder after inflation or expansion to administer a treatment drug solution over an extended period of time.